Adalvo: Exploring European B2B Pharma’s Next Steps
Sponsored by :
Listen now as Citeline speaks with Anil Okay, CEO of Europe’s fast-growing pharma B2B, Adalvo. Learn what the company’s recent acquisition by private equity firm EQT means for both Adalvo and for the industry at large, and find out what trends will be fueling pharma in the years ahead.
Keep up with the top pharma business news of the week. On the go.
Sponsored by :